Chapter 6: Science & Engineering Indicators 93

International Patenting Trends for Three Important Technologies

(Click here for footnote 42.)
This section explores the relative strength of America's technological position by examining international patenting patterns in the critical technologies of advanced manufacturing, biotechnology, and information technology. (Click here for footnote 43.) To facilitate patent search and analysis, these broad technology areas were each represented by a narrower subfield: robot technology was used as a proxy for advanced manufacturing, genetic engineering (recombinant DNA--rDNA--techniques) was used for biotechnology, and optical fibers were used to represent patent activity in information technology. (Click here for footnote 44.) To ensure maximum comparability of data, the unit of analysis used in this discussion is built around the concept of a "patent family"--i.e., all the patent documents published in different countries associated with a single invention. (See "International Patent Families as a Basis of Comparison.")

In this section, three indicators are used to compare national positions in each critical technology.


Footnote 42:
Data in this section are drawn from a database containing patent records from 33 major patenting countries, which facilitates a more comprehensive assessment of the U.S. technological position vis-a-vis other national competitors. These data were developed under contract for the National Science Foundation by Mogee Research & Analysis Associates; they were extracted from the World Patents Index database published by Derwent Publications, ltd.


Footnote 43:
The technology areas selected for this study met several criteria:


Footnote 44:
These subfields were identified based on a review of recent critical technologies reports and extensive consultation with National Science Foundation staff and experts in the technologies to determine representative subfields.


Footnote 45:
In many countries, patent applications are published, automatically, 18 months after the priority filing.


Footnote 46:
Carpenter, Narin, and Woolf (1981) show that technologically important U.S. patents on average receive twice as many examiner citations as does the average U.S. patent, thus helping to confirm the validity of interpatent citation as an indicator of patent quality. Albert, Avery, Narin, and McAllister (1991) show that citation counts prove to be a useful tool in identifying commercially important patents.


Footnote 47:
The citations counted are those placed on patents filed with the European Patent Office (EPO) by EPO examiners, since EPO citations are believed to be a less biased and broader source of citations than those of the U.S. Patent and Trademark Office. See Claus and Higham (1982).


Footnote 48:
Citation data are based on the total number of patent families, not just the international families.


Footnote 49:
Operationally, this means counting the number of countries in a family in which a patent publication (i.e., a published patent application or an issued patent) exists.


ContentsSearchContinue